Shortly after the release of the public health advisory, fda and glaxosmithkline notified healthcare professionals of revisions to the warnings and precautions sections of paxil labeling to alert healthcare professionals that patients with major depressive disorder, both adult and pediatric, may experience worsening of their depression and or the emergence of suicidal ideation and behavior suicidal tendencies , whether or not they are taking antidepressant medications.
Continue Reading →